Send by AHN | All Headline News

Vivitrol, made by Massachusetts drug maker Alkermes, is a so-called extended-release formulation of the drug naltrexone that is injected once a month into [...]

Send by Forbes

AP , 10.13.10, 09:25 AM EDT Shares of Alkermes Inc. edged higher in premarket trading Wednesday after regulators granted broader marketing approval to its [...]

Send by FiercePharma

Alkermes has won the FDA nod to promote its alcoholism treatment Vivitrol as an aid for patients hooked on opioids, including prescription painkillers and [...]

Send by The Associated Press

WASHINGTON — Drugmaker Alkermes Inc. said Tuesday it has received US approval to market its addiction medication for use in patients addicted to narcotics [...]

Send by The Brilliant Stories

If you are into Naked Lunch by William Burroughs “where the days glide by strung on a syringe with a long thread of blood”, Alkermes will snap the mood of [...]

16 Sep 2010 That is key as Alkermes now loses money making the drug, Alkermes shares have risen more than 51 percent so far this year ahead of the [...]

Get detailed financial information on Alkermes, Inc. (NASDAQ:ALKS) including real-time stock quotes, historical charts & financial news, all for free! [...]

16 Sep 2010 It's a busy day at the FDA today as panels meet to discuss two new drugs -- one to help weight loss and the other to combat drug addiction [...]

ALKERMES. A biotechnology company committed to developing innovative medicines to improve UPDATE 1-US FDA cites concerns with Alkermes addiction drug [...]

Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes developed [...]

Early Market-Movers: Crucell, Alkermes Stock futures were pointing to a higher opening following strong earnings from tech companyies Oracle (NASDAQ:ORCL) and Research in Motion (NASDAQ:RIMM). Read more on FOX Business. Related Posts [...]

Send by Ramona Bates MD

Vivitrol is manufactured by Alkermes, Inc. Related stories. Positive Information About VIVITROL For Treatment Of Alcoholism · Prescription Drug Abuse Touches Everyone · Alcohol Abuse, Addiction Affect Suicide Rates [...]

NEW YORK (MarketWatch) -- Shares of Alkermes Inc. were halted for trading Thursday as a federal review board meets to review the biotechnology company's. [...]

Send by Luke Timmerman

Richard Pops is not the sort of guy to sit still and patiently wait for good things to happen. He took the CEO job at Cambridge, MA-based Alkermes when he was. [...]

Send by campingantipolis

Alkermes, Inc. (NASDAQ: ALKS) announced that the US. Go here to read the rest: Alkermes Announces FDA Advisory Committee Recommends Approval Of VIVITROL(R) For Opioid Dependence. [...]

The US FDA has confirmed that its psychopharmacological drugs advisory committee will meet on 16 September to review Alkermes' supplemental NDA for Vivitrol, its injectable once-monthly formulation of naltrexone, for the treatment of [...]

Alkermes stock trading halted today Alkermes Inc. said that NASDAQ has halted trading of the company’s common stock this morning. Alkermes – Business – NASDAQ – Investing – Stocks and Bonds Read more on Boston Globe [...]

Alkermes Inc. said Thursday a US Food and Drug Administration committee is recommending the agency approve the biotechnology company's drug Vivitrol for the treatment of opioid dependence. [...]

Send by Health News from Medical News

Alkermes, Inc. (NASDAQ: ALKS) announced that the US Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted 12 to 1 that VIVITROL® (naltrexone for extended-release injectable suspension) should be approved [...]

Send by [email protected] (BioPha

Expect large gains for Alkermes tomorrow. I wouldn't sell the stock as they have another approval up on Oct. 22nd in conjunction with Amylin and Eli Lilly for Bydureon, a weekly injectible diabetes medication. [...]

Send by SlaveNoMore

Alkermes Announces FDA Advisory Committee Recommends Approval Of VIVITROL® Fοr Opioid Dependence Alkermes, Inc. (NASDAQ: ALKS) announced tһаt tһе US Food аחԁ Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted [...]

Send by Jay

FDA to Review Arena's Diet Drug, Alkermes' Painkiller Addiction MedDailyFinanceSeveral companies have attempted to create a safe diet drug over the years, but ever since the debacle 13 years ago of combination drug phen-fen, [...]

Send by TheStreet.com

Let's start with the consensus favorites: Alkermes tops the list, with 84% of readers predicting full approval for Vivitrol opioid, the company's [...]

Send by Behavioral Health Central (blo

WASHINGTON ? Although Alkermes Inc.'s single study of Vivitrol (naltrexone for extended-release injectable suspension) provided evidence of efficacy to [...]

Send by Melly Alazraki

FDA to Review Arena's Diet Drug, Alkermes' Painkiller Addiction Med. Melly Alazraki | 16 September 2010, 6:45 am. FDA meets to discuss weight-loss drug and painkiller addiction med. It's a busy day at the FDA today as panels meet to [...]